CA
ABT icon

Clune & Associates’s Abbott ABT Stock Holding History

Clune & Associates’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
12,530
+11
+0.1% +$1K 0.17% 78
2026
Q1 		$1.29M Sell
12,519
-2,058
-14% -$232K 0.24% 78
2025
Q4 		$1.83M Sell
14,577
-103
-0.7% -$13.1K 0.39% 64
2025
Q3 		$1.97M Sell
14,680
-114
-0.8% -$15K 0.49% 56
2025
Q2 		$2.01M Sell
14,794
-123
-0.8% -$16.2K 0.55% 51
2025
Q1 		$1.98M Buy
14,917
+376
+3% +$47.9K 0.61% 50
2024
Q4 		$1.64M Buy
+14,541
New +$1.68M 0.55% 53

Other funds holding ABT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Clune & Associates's ABT Position: Q2 2026 in Review

Clune & Associates increased its Abbott (ABT) stake by 0.09% in Q2 2026, buying an estimated $1K and bringing the position to 12,530 shares worth $1.14M. The position accounts for 0.17% of the portfolio, ranked #78.

Clune & Associates first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.01M in Q2 2025. 684 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Clune & Associates held 12,530 shares of Abbott worth $1.14M as of Q2 2026.
  • Clune & Associates bought 11 Abbott shares in Q2 2026, an estimated $1K.
  • Abbott made up 0.17% of Clune & Associates's portfolio in Q2 2026, its #78 holding.
  • Clune & Associates first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Clune & Associates's Abbott position peaked at $2.01M in Q2 2025.
  • 684 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Clune & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.